Efficacy and Toxicity Assessment of Different Antibody Based Antiangiogenic Drugs by Computational Docking Method

Figure 4

Docked conformation of bevacizumab (a), trastuzumab (b), risperidone (c), and cabergoline (d) to dopamine-2 receptor (in cyan color).

(a)

(b)

(c)

(d)